Synthesis of overlapping fibrin citrullinated peptides and their use for diagnosing rheumatoid arthritis

Chemical Biology and Drug Design

Volumn 68, Issue 4, 2006, Pages 194-200

  Pérez, María L ^a   Gómara, María J ^a   Kasi, Devi ^a   Alonso, Ana ^a   Viñas, Odette ^b   Ercilla, Guadalupe ^b   Sanmartí, Raimon ^b   Haro, Isabel ^a  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Citrulline; Diagnosis; Enzyme linked immunosorbent assay; Fibrin; Rheumatoid arthritis; Synthetic peptides

Indexed keywords

ALPHA FIBRIN[122-138][123,129,135,137 CITRULLINE]; ALPHA FIBRIN[123-138][129,135,137 CITRULLINE]; ALPHA FIBRIN[612-631][621,627,630 CITRULLINE]; ALPHA FIBRIN[617-631][621,627,630 CITRULLINE]; AUTOANTIBODY; CITRULLINE; DIAGNOSTIC AGENT; FIBRIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIGENICITY; ARTICLE; BETA CHAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; MAJOR CLINICAL STUDY; PEPTIDE SYNTHESIS; PREDICTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FIBRIN; HUMANS; IMMUNODOMINANT EPITOPES; INTERMEDIATE FILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, PROTEIN;

EID: 33751061883     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00438.x     Document Type: Article

References (24)

1. Silman A.J., Pearson J.E. (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res;4 (Suppl. 3):S265-S272.
2. Boers M. (2003) Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum;48:1771-1774.
3. Smolen J.S. (1996) Rheumatoid Factor. In: Maini R.N., Avan Venrooij W.J., editors. Manual of Biological Markers of Disease. Dordrecht, the Netherlands: Kluwer Academic Publishers;p. 4-8.
4. Schellekens G.A., Visser H., de Jong B.A., van der Hoogen F.H., Hazes J.M., Breedveld F.C., van Venrooij W.J. (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum;43:155-163.
5. Vossenaar E.R., van Venrooij W.J. (2004) Anti-CCP antibodies, a highly specific marker for early rheumatoid arthritis. Clin Appl Immunol Rev;4:239-262.
6. Pinherio G.C., Scheinberg M.A., Aparecida da Silva M., Maciel S. (2003) Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis. Ann Intern Med;139:234-235.
7. Vasishta A. (2002) Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab;221:34-38.
8. Dubucquoi S., Solau-Gervais E., Lefranc D., Marguerie L., Sibilia J., Goetz J., Dutoit V., Fauchais A.L., Hachulla E., Flipo R.M., Prin L. (2004) Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis;63:415-419.
9. Baeten D., Peene I., Union L., Meheus L., Sebbag M., Serre G., Veys E.M., De Keyser F. (2001) Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synouium: relevance to antifilaggrin autoantibodies. Arthritis Rheum;44:2255-2262.
10. Vossenaar E.R., van Venrooij W.J. (2004) Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther;6:107-111.
11. Masson-Bessiere C., Sebbag M., Girbal-Neuhauser E., Nogueira L., Vincent C., Senshu T., Serre G. (2001) The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol;166:4177-4184.
12. Nogueira N.L., Sebbag M., Regaud S.C., Clavel C., Fournie B., Cantagrel A., Vincent C., Serre G. (2002) Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for the diagnosis of rheumatoid arthritis. Arthritis Res;4:90-96.
13. Chapuy-Regaud S., Nogueira L., Clavel C., Sebbag M., Vincent C., Serre G. (2003) Subclass distribution of IgG autoantibodies to deiminated fibrinogen in rheumatoid arthritis. Arthritis Res;4:S2.
14. Hopp T.P., Woods K.R. (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A;78:3824-3828.
15. Janin J. (1979) Surface and inside volumes in globular proteins. Nature;277:491-492.
16. Welling G.W., Weijer W.J., van der Zee R., Welling-Wester S. (1985) Prediction of sequential antigenic regions in proteins. FEBS Lett;188:215-228.
17. Chou P.Y., Fasman G.D. (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol;47:45-48.
18. Young B.J., Mallya R., Leslie R.D., Clark C.J., Hamblin T.J. (1979) Anti-keratin antibodies in rheumatoid arthritis. Br Med J;11:97.
19. Gómara M.J., Riedemann S.M., Vega I., Ibarra H., Ercilla G., Haro I. (2000) Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. J Immunol Methods;234:23-34.
20. Pérez T., Gómez A., Sanmartí R., Viñas O., Ercilla G., Haro I. (2002) Use of [Cit312,314] filaggrin (306-324) analogue for the diagnosis of rheumatoid arthritis. Conformational study by circular dichroism and Fourier transformed infrared spectroscopy. Lett Pept Sci;9:291-300.
21. Wagner U., Kaltenhauser S., Sauer H., Arnold S., Seidel W., Hantzchel H et al. (1997) HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum;40:341-351.
22. Van Zeben D., Hazes J.M., Zwinderman A.H., Cats A., Schreuder G.M., D'Amaro J et al. (1991) Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis: results of a followup study. Arthritis Rheum;34:822-830.
23. Gregensen P.K., Silver J., Winchester R.J. (1987) The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum;30:1205-1213.
24. Hill J.A., Southwood S., Sette A., Jevnikar A.M., Bell D.A., Cairns E. (2003) The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol;171:538-541.